Link to this page
The Drug-Drug Interactions Ontology
| Preferred Name | ezogabine | |
| Synonyms |
Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester D-23129 ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate ethyl N-(2-amino-4-{[(4-fluorophenyl)methyl]amino}phenyl)carbamate retigabine Potiga C16H18FN3O2 |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_68584 |
|
| AHFScode |
28:12.92
|
|
| ATCCode |
N03AX21
|
|
| binds |
http://purl.obolibrary.org/obo/dinto_2496 http://purl.obolibrary.org/obo/dinto_3118 http://purl.obolibrary.org/obo/dinto_3115 http://purl.obolibrary.org/obo/dinto_3116 http://purl.obolibrary.org/obo/dinto_4068 http://purl.obolibrary.org/obo/dinto_1892 http://purl.obolibrary.org/obo/dinto_0265 http://purl.obolibrary.org/obo/dinto_0270 |
|
| CASRN |
150812-12-7
|
|
| DBBrand |
potiga
|
|
| DBSynonym |
d23129 d-23129 retigabine ezg rtg
|
|
| Definition |
Ezogabine (D23129) is a close structural analog of the centrally acting analgesic flupitrine. It is a neuronal potassium channel opener being developed as a first-in-class antiepileptic drug (AED) and is currently being studied in Phase 3 trials as an adjunctive treatment for partial-onset seizures in adult patients with refractory epilepsy. FDA approved in June 10, 2011 under the name of ezogabine. A substituted aniline that is benzene-1,2,4-triamine bearing ethoxycarbonyl and 4-fluorobenzyl substituents at positions N-1 and N-4 respectively. An anticonvulsant used to treat seizures associated with epilepsy in adults.
|
|
| has role | ||
| InChI |
InChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21)
|
|
| InChIKey |
InChIKey=PCOBBVZJEWWZFR-UHFFFAOYSA-N
|
|
| inhibits | ||
| is metabolised by |
http://purl.obolibrary.org/obo/dinto_1892 http://purl.obolibrary.org/obo/dinto_0265 http://purl.obolibrary.org/obo/dinto_0270 |
|
| is substrate of |
http://purl.obolibrary.org/obo/dinto_1892 http://purl.obolibrary.org/obo/dinto_0265 http://purl.obolibrary.org/obo/dinto_0270 |
|
| label |
ezogabine
|
|
| may interact with |
http://purl.obolibrary.org/obo/CHEBI_8107 http://purl.obolibrary.org/obo/dinto_DB00904 |
|
| prefixIRI |
obo2:CHEBI_68584
|
|
| prefLabel |
ezogabine
|
|
| related with |
http://purl.obolibrary.org/obo/dinto_3118 http://purl.obolibrary.org/obo/dinto_3115 |
|
| SMILES |
CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
|
|
| Synonym |
Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester D-23129 ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate ethyl N-(2-amino-4-{[(4-fluorophenyl)methyl]amino}phenyl)carbamate retigabine Potiga C16H18FN3O2
|
|
| xref |
PubChem Compound:121892 Patent:US2012053238 Reaxys:8072099 KEGG DRUG:D09569 Wikipedia:http://en.wikipedia.org/wiki/Retigabine CiteXplore:22991134 Patent:US6348486 Drugs.com:http://www.drugs.com/mtm/ezogabine.html CASRN:150812-12-7 PharmGKB:PA144997862 PubChem Substance:10239851 ChEMBL:161945 Patent:US5384330 Patent:WO2007090409 ChEBI:68584 BindingDB:50143558 Patent:US2002111379 Patent:US2002015730 Patent:WO2011012659 ChemSpider:108740 RxList:http://www.rxlist.com/potiga-drug.htm KEGG COMPOUND:C13826 National Drug Code Directory:0173-0814-59 Patent:US2002183395 Wikipedia:Ezogabine
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |